An analysis of more than one million post-9/11 veterans suggests a new diagnosis of post-traumatic stress disorder (PTSD) is associated with a greater likelihood of developing atrial fibrillation (AF). The study is scheduled to be presented May 11 at the Heart Rhythm Society’s annual scientific sessions in Boston.

Despite normal baseline blood pressures without medications before 20 weeks of gestation, pregnant women with chronic hypertension are at an increased risk of poor outcomes compared with women without, according to new research published in the May issue of Obstetrics & Gynecology.

Occluding the left atrial appendage with the Watchman device proved to be a cost-effective strategy for the secondary prevention of stroke among patients with atrial fibrillation (AFib), according to an analysis published in Stroke.

Requiring hospitals and physicians to publicly report their mortality outcomes related to percutaneous coronary intervention (PCI) causes many interventional cardiologists to forego high-risk procedures, researchers reported in JAMA Cardiology.

A new study from Hong Kong found adults with type 2 diabetes and hypertension who achieved a systolic blood pressure (SBP) of less than 130 mmHg did not experience a reduction in cardiovascular risk, compared to patients with SBPs between 130 and 140 mm Hg. The study’s findings were published in Diabetes Care.

A four-step protocol designed to improve care for all patients who experience ST-segment elevation myocardial infarction (STEMI) also reduced gender-specific disparities in suboptimal care and clinical outcomes, Cleveland Clinic researchers reported in the Journal of the American College of Cardiology.

Medtronic’s Micra Transcatheter Pacing System (TPS) demonstrated a major complication rate of 2.7 percent through one year, according to data from a post-approval registry that will be presented May 10 at the Heart Rhythm Society’s annual scientific sessions in Boston.

SEATTLE, May 9, 2018 — Bardy Diagnostics, Inc., ("BardyDx"), a leading provider of ambulatory cardiac monitoring technologies and custom data solutions, including the Carnation Ambulatory Monitor ("CAM™"), the world's only P-wave centric™ ambulatory cardiac patch monitor and arrhythmia detection device, presented a poster today titled "Artificial Intelligence for the Automatic Detection of Atrial Fibrillation" at the Heart Rhythm Society 39th Annual Scientific Sessions that described a validated artificial intelligence-enabled (AI) screening technology to detect atrial fibrillation (AF) events.